BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/8/2024 3:51:26 AM | Browse: 40 | Download: 185
 |
Received |
|
2024-05-17 11:48 |
 |
Peer-Review Started |
|
2024-05-17 11:48 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-09-15 05:31 |
 |
Revised |
|
2024-10-15 21:19 |
 |
Second Decision |
|
2024-10-24 02:43 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-10-24 10:35 |
 |
Articles in Press |
|
2024-10-24 10:35 |
 |
Publication Fee Transferred |
|
2024-10-20 10:47 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-10-31 08:30 |
 |
Publish the Manuscript Online |
|
2024-11-08 03:51 |
ISSN |
2307-8960 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Case Report |
Article Title |
Pan-TRK positive uterine sarcoma in immunohistochemistry without neurotrophic tyrosine receptor kinase gene fusions: A case report
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Seungmee Lee, Yu-Ra Jeon, Changmin Shin, Sun-Young Kwon and Sojin Shin |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea |
RS-2022-KH129889 |
|
Corresponding Author |
Sojin Shin, MD, PhD, Professor, Department of Obstetrics and Gynecology, Keimyung University School of Medicine, 1035 Dalgubeol-daero, Dalseo-gu, Daegu 42601, South Korea. hope2014@dsmc.or.kr |
Key Words |
Uterine sarcoma; Cervical sarcoma; Neurotrophic tyrosine receptor kinase gene fusion; Next generation sequencing; Case report |
Core Tip |
This case report highlights a rare malignant mesenchymal tumor originating from the uterine cervix that was pan-TRK immunohistochemistry-positive but lacked neurotrophic tyrosine receptor kinase (NTRK) gene fusions. Although NTRK-fusion sarcomas are aggressive and may benefit from targeted TRK inhibitor therapy, this case underscores the importance of molecular genetic diagnostics to guide accurate treatment decisions. The report contributes to the limited literature on NTRK-positive uterine sarcomas and emphasizes the potential clinical value of TRK inhibitors in selected cases. |
Publish Date |
2024-11-08 03:51 |
Citation |
<p>Lee S, Jeon YR, Shin C, Kwon SY, Shin S. Pan-TRK positive uterine sarcoma in immunohistochemistry without neurotrophic tyrosine receptor kinase gene fusions: A case report. <i>World J Clin Cases</i> 2025; 13(2): 96876</p> |
URL |
https://www.wjgnet.com/2307-8960/full/v13/i2/96876.htm |
DOI |
https://dx.doi.org/10.12998/wjcc.v13.i2.96876 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345